- Home
- ARVN vs WTBA Comparison
ARVN vs WTBA Comparison
Compare ARVN & WTBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARVN | WTBA |
|---|---|---|
| Founded | 2015 | 1893 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 516.2M | 419.4M |
| IPO Year | 2018 | 2002 |
Fundamental Metrics
Financial Performance| Metric | ARVN | WTBA |
|---|---|---|
| Price | $8.11 | $27.19 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 19 | 1 |
| Target Price | $15.05 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 685.8K | 80.8K |
| Earning Date | 05-04-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 4.17% |
| EPS Growth | ★ 58.84 | 35.21 |
| EPS | N/A | ★ 0.61 |
| Revenue | ★ $262,600,000.00 | N/A |
| Revenue This Year | N/A | $23.80 |
| Revenue Next Year | N/A | $9.39 |
| P/E Ratio | ★ N/A | $45.28 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.06 | $17.50 |
| 52 Week High | $14.22 | $27.87 |
Technical Indicators
Market Signals| Indicator | ARVN | WTBA |
|---|---|---|
| Relative Strength Index (RSI) | 45.64 | 59.53 |
| Support Level | N/A | $22.58 |
| Resistance Level | $8.90 | $27.62 |
| Average True Range (ATR) | 0.38 | 0.79 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 18.50 | 60.09 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.
About WTBA West Bancorporation
West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings, and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America.